What is Tandem Diabetes Care Price-to-Free-Cash-Flow?
As of today (2024-12-14), Tandem Diabetes Care's share price is €32.54.
Tandem Diabetes Care's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.53. Hence, Tandem Diabetes Care's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Tandem Diabetes Care's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 13 years, Tandem Diabetes Care's highest Price-to-Free-Cash-Flow Ratio was 8230.00. The lowest was 49.57. And the median was 127.22.
FRA:TD5A's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 32.82 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -117.40% per year.
During the past 13 years, Tandem Diabetes Care's highest 3-Year average Free Cash Flow per Share Growth Rate was 78.50% per year. The lowest was -117.40% per year. And the median was 17.00% per year.
Tandem Diabetes Care Price-to-Free-Cash-Flow Historical Data
The historical data trend for Tandem Diabetes Care's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Tandem Diabetes Care Price-to-Free-Cash-Flow Chart
Competitive Comparison of Tandem Diabetes Care's Price-to-Free-Cash-Flow
For the Medical Devices subindustry, Tandem Diabetes Care's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tandem Diabetes Care's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Tandem Diabetes Care's Price-to-Free-Cash-Flow falls into.
Tandem Diabetes Care Price-to-Free-Cash-Flow Calculation
Tandem Diabetes Care's Share Price of today is €32.54. Tandem Diabetes Care's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.53.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Tandem Diabetes Care (FRA:TD5A) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Tandem Diabetes Care Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Tandem Diabetes Care's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:TD5A has been successfully added to your 